FDA Investigator Mark E Baldwin
Mark E Baldwin has conducted inspections on 54 sites in 1 countries as of 11 Jan 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
54
Last Inspection Date:
11 Jan 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Mark E Baldwin:
Alex G Kalugin,
Alice A Blair,
Andrew E Kay,
Andrew T Todd,
Angel K Sandhu,
Angela D Wise,
Anna L Marroquin,
Anna L Viveros Hernandez,
Armando Morales,
Brandon R Boone,
Brian R Yaun,
Cambria Cook Krueger,
Capri R Woolridge,
Carl Lee,
Cathie S Marshall,
Celeste K Wong,
Christine M Parmentier,
Christopher J Lee,
Cindy W Lewis,
Courtney R Bolton,
Courtney R Warren,
Cristina Resendiz Navarrete,
Daniel C Geffin,
Daniel Velasquez,
David P Moorhead,
Deanna L Lampley,
Douglas J Snyder,
Edna J Hidalgo,
Edward D Harris,
Edwardstine J Reese,
Elizabeth P Mayer,
Elodie X Tong Lin,
Elva M Ibarra,
Emal Wahab,
Erica L Nicoll,
Erica R Pomeroy,
Estefania Fernandez,
Frank P Bianco,
Gillenwater,
Greg K Keshishyan,
Gulshan R Anand,
Helen J Hamaoka,
Herbert E Arden,
Humberto Z Gomez,
Ingrid A Zambrana,
Ismael Garibay,
James C Yee,
Janice Wai,
Jazmine M Welcher,
Jessica B Darneille,
Joanne M Fukuda,
John A Liu,
John Fox,
Jolene S Hedgecock,
Joseph M Willems,
Juliane Kjung Lau,
Kacie M Crowther,
Karen D Phung,
Karen J Bak,
Karen M Willis,
Karl D Hezel,
Karla J Gibler,
Katie T Duong,
Kevin T Gerrity,
Kimberlee Wood,
L'oreal F Walker,
Larkin R Buckalew,
Lauren E Burke,
Ligia M Sanders,
Lija V Fellows,
Lillian C Lopez,
Linda S Jozefiak,
Lirissia Mccoy,
Lisa H Nakagawa,
Lopez,
Lorenzo F Edwards,
Lorraine N Williams,
Lucila B Nwatu,
Macropolk,
Maridali Deleon Torres,
Marjorie D Santos,
Martin R Vowell,
Matthew A Walburger,
Mcgrewp,
Michelle L Jones,
Michelle L Tripp,
Monique C Lo,
Nicole Yuen,
Owens,
Phung,
Randall F Albright,
Randall J Plunkett,
Randall P Zielinski,
Raymond Souweha,
Rebecca E Sulpacio,
Richard L Bartlett,
Robles,
Roger A Hartman,
Ronald P Boyce,
Sara M Richardson,
Sergio Chavez (NMI),
Shelley H Beausoleil,
Sondra R Davis,
Steve P Yost,
Steven J Branch,
Steven M Galvez,
Stuart W Russell,
Teresa I Navas,
Terrence Gee,
Thomas N Adjabeng,
Thomas W Gordon,
Tomanik'e C Banks,
Travelle D Mason,
Twana R Chandler,
Vesa Vuniqi,
William J Weis,
Zachary Ryan Harris
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more